skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

A unique perspective on the personal care industry


How it helps

In the largely self-regulated personal care industry, it’s easy to forget how critical knowledge of class actions, legal risks, and product liability issues can be. Rose Sheet’s unique, objective viewpoint combines deep analysis of current market news with coverage of all the regulatory, legislative, legal, and business concerns that go along with it.  

How it works

Rose Sheet features in-depth coverage of topics including: 

  • Legislative developments in the US that tighten cosmetics regulations, plus developments in the EU and various emerging international markets
  • Ingredient safety, transparency and product liability issues  
  • “Natural” and ”organic” formulation, regulation, claims, and legal implications
  • Business development, marketing, and advertising strategies
  • New product launches, trademark reviews, cosmetic ingredients, science, and innovation
  • Dietary supplements, business developments, and safety issues

Protect your interests with exclusive information and analysis from Rose Sheet. 


How we've helped other businesses

"Scrip helps me to stay current with pharmaceutical news on a world-wide basis."

​Wendy Johnson ​CEO, Aires Pharmaceuticals, USA

"RxScorecard™ provides a comprehensive, multi-pronged rubric assisting us in decision-making as we begin to move from a volume to value drug evaluation methodology."

​Chronis H. Manolis, RPh ​Vice President, Pharmacy UPMC Health Plan

"RxScorecard™ lets a biopharma company anticipate the most important factors impacting the clinical & economic value of pipeline and marketed drugs -- and then helps identify the necessary changes to the clinical development and commercial program to maximize that value for all stakeholders, especially including payers. It's a required, straightforward, objective strategic tool that allows us to quickly and effectively adapt to a rapidly changing and much more challenging market access environment."

​Ammar Qadan ​Global Value/Market Access Lead Oncology Portfolio & Global Commercial Lead Oncology Biomarkers Halozyme Therapeutics, Inc.

Next steps

Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: